May 27, 2026 08:00AM
Mar 9, 2026 04:30PM
Feb 3, 2026 08:00AM
Nov 6, 2025 04:15PM
Aug 5, 2025 08:00AM
May 28, 2025 08:00AM
Feb 4, 2025 08:00AM Mesa Labs Announces Third Quarter Results
Nov 7, 2024 08:00AM
Aug 5, 2024 08:00AM
Jun 5, 2024 06:00AM
May 31, 2024 06:00AM
Apr 8, 2024 08:00AM
Feb 5, 2024 08:00AM
Jan 8, 2024 08:00AM Mesa Laboratories Appoints Mark Capone to its Board of Directors
Jan 3, 2024 08:00AM
Jan 3, 2024 08:00AM
Nov 6, 2023 08:00AM
Oct 16, 2023 05:55AM
Oct 16, 2023 03:00AM
Aug 3, 2023 08:00AM
May 25, 2023 08:00AM Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results
Feb 6, 2023 08:36AM
Nov 17, 2022 08:06AM
Nov 17, 2022 08:04AM
Nov 17, 2022 08:04AM
Nov 3, 2022 08:00AM
Jun 27, 2022 08:03AM
Jun 27, 2022 08:01AM Mesa Laboratories Appoints Tony Tripeny to its Board of Directors
Jun 27, 2022 08:01AM
May 31, 2022 08:00AM
Feb 3, 2022 08:00AM
Nov 4, 2021 08:00AM
Oct 20, 2021 12:05PM
Oct 20, 2021 12:05PM
Sep 14, 2021 07:01AM Mesa Laboratories (MLAB) Acquires Agena Bioscience, Inc for $300M
Sep 14, 2021 07:00AM
Sep 14, 2021 07:00AM
Jun 1, 2021 08:00AM
Feb 3, 2021 08:00AM
Nov 5, 2020 08:00AM
Jun 1, 2020 08:00AM
Feb 10, 2020 08:00AM Mesa Labs Reports Third Quarter Results
Nov 11, 2019 09:41AM
Nov 11, 2019 09:40AM
Nov 6, 2019 08:00AM
Nov 1, 2019 05:46AM
Oct 31, 2019 08:55PM
Oct 31, 2019 08:55PM
Aug 12, 2019 04:05PM Mesa Laboratories, Inc. Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options
Aug 12, 2019 04:05PM

1,160,212 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All